Connect with us

Hi, what are you looking for?


Meta stock price forecast: Mark Mahaney sees another 45% upside

Meta Platforms Inc (NASDAQ: META) has already nearly doubled since the start of this year but a prominent Wall Street analyst remains convinced that the stock is not out of room to run just yet.

Meta stock is still inexpensive

On Tuesday, Evercore ISI’s head of internet research Mark Mahaney reiterated the tech behemoth as his top pick.

His $350 price target on Meta stock suggests more than a 45% upside from here. In a recent interview with CNBC, the analyst said:

I still like Meta because the valuation, I think, is still super attractive. It’s trading at a discount to the market and is a company that can sustain 20% plus earnings growth. You don’t see that too often.

Last week, Meta Platforms reported a strong first quarter and issued upbeat guidance for the future (find out more).

Meta is aggressively cutting costs

Mahaney likes the Nasdaq-listed firm for its commitment to cutting costs as well. In March, Meta Platforms revealed plans of cutting another 10,000 jobs to prepare for an economic downturn.

Other reasons cited for the bullish view on Meta stock included “click to message” advertising. The analyst said:

I think this is a global opportunity but it’s particularly strong in markets where WhatsApp is strong. They’re finally starting to figure out how to monetise this effectively. So, there’s a lot of upside still.

Reels, he expects, will contribute more and more to growth moving forward. Note that Meta Platforms Inc is well positioned in artificial intelligence as well.    

The post Meta stock price forecast: Mark Mahaney sees another 45% upside appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.